C60-fullerene binds with the ATP binding domain of human DNA topoiosmerase II alpha

J Biomed Nanotechnol. 2011 Feb;7(1):177-8. doi: 10.1166/jbn.2011.1257.

Abstract

C60-fullerene has promising biological applications, such as drug delivery, biosensors, diagnosis and theraupetics. Despite of these applications, several in vitro studies have also reported the DNA damaging potential of this nanomaterial. Though, very little is known about the mechanism involved behind the fullerene mediated DNA damage. Our study was aimed at identifying the binding site of fullerene in the ATP binding domain of human topoisomerase II alpha, a major enzyme involved in maintaining DNA topology. In silico studies of fullerene with the enzyme demonstrated that it can interact with the active site residues of this enzyme through hydrophobic, pi-stacking and van der Waals interactions and could inhibit the activity of this enzyme.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / chemistry*
  • Antigens, Neoplasm / chemistry*
  • Antigens, Neoplasm / ultrastructure
  • Binding Sites
  • Computer Simulation
  • DNA Topoisomerases, Type II / chemistry*
  • DNA Topoisomerases, Type II / ultrastructure
  • DNA-Binding Proteins / chemistry*
  • DNA-Binding Proteins / ultrastructure
  • Enzyme Activation
  • Fullerenes / chemistry*
  • Humans
  • Models, Chemical*
  • Models, Molecular*
  • Protein Binding
  • Protein Structure, Tertiary

Substances

  • Antigens, Neoplasm
  • DNA-Binding Proteins
  • Fullerenes
  • Adenosine Triphosphate
  • DNA Topoisomerases, Type II
  • fullerene C60